|
Market Cap (11-Jun) $6,895,205 (0th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 172,500 |
Shortsold (16-Jun) 5,714 (0.00%) (567th) |
|
52w High $0.048 |
52w Low $0.017 |
P/E - |
EPS -0.01 |
IRX released this announcement to the ASX on 30 March 2022, 9:31. The announcement is not marked as price sensitive, and is 2 page(s) in length and 174.25kb in size.
You can view all announcements from IRX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IRX was 0.002% short sold according to ASIC data. It was ranked the 632nd most shorted stock on the ASX. It is now ranked as the 567th most shorted stock on the ASX with 0.003% of total shares short sold as of the latest reported data (16 June 2025).
| Other Recent Announcements from IRX | |
|---|---|
| First Cohort Complete for Phase 1, Pain Indication IRX211 | 14 June 2023, 9:56 |
| First Patient Dosed for Phase 1, Pain Indication IRX211 | 7 June 2023, 9:54 |
| Constitution | 6 June 2023, 17:05 |
| IRX granted wholesale licenses for scheduled substances | 30 March 2022, 9:31 |
| Preliminary Final Report | 28 February 2022, 10:42 |
| Quarterly Activities Report | 31 January 2022, 14:15 |
| Quarterly Appendix 4C Cash Flow Report | 31 January 2022, 10:02 |
You must be logged in to post a reply.
